BALANCE SHEETS - USD ($)	Mar. 31, 2020	Sep. 30, 2019
CURRENT ASSETS:
Cash and cash equivalents	$ 14,329,870	$ 8,444,774
Receivables	62,289	62,765
Prepaid expenses	565,246	524,953
Supplies used for R&D and manufacturing	849,548	782,363
Total current assets	15,806,953	9,814,855
Finance lease right of use assets	14,670,746	0
Operating lease right of use assets	899,508	0
Plant, property and equipment, net	3,286,273	15,825,636
Patent costs, net	312,380	311,586
Deposits	1,670,917	1,670,917
Total assets	36,646,777	27,622,994
CURRENT LIABILITIES:
Accounts payable	1,139,914	1,586,478
Accrued expenses	316,866	34,432
Due to employees	675,408	709,442
Derivative instruments, current portion	2,156,857	674,442
Lease liabilities, current portion	977,264	0
Other current liabilities	5,000	14,956
Total current liabilities	5,271,309	3,019,750
Derivative instruments - net of current portion	4,067,436	5,813,868
Finance lease obligations, net of current portion	12,232,493	13,508,156
Operating lease obligations, net of current portion	812,479	0
Other liabilities	125,000	147,553
Total liabilities	22,508,717	22,489,327
Commitments and contingencies	0	0
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value - 200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 37,336,411 and 35,231,776 shares issued and outstanding at March 31, 2020 and September 30, 2019, respectively	373,365	352,318
Additional paid-in capital	379,943,932	358,507,603
Accumulated deficit	(366,179,237)	(353,726,254)
Total stockholders' equity	14,138,060	5,133,667
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 36,646,777	$ 27,622,994